KALARIS THERAPEUTICS, INC. Other Comprehensive Income (Loss), Net of Tax
KALARIS THERAPEUTICS, INC. (KLRS) reported Other Comprehensive Income (Loss), Net of Tax of -$24.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTax · last filed 2026-08-11
- KALARIS THERAPEUTICS, INC. other comprehensive income (loss), net of tax for the quarter ending 2026-06-30 was -$24.00K.
- KALARIS THERAPEUTICS, INC. other comprehensive income (loss), net of tax for the quarter ending 2026-03-31 was -$55.00K.
- KALARIS THERAPEUTICS, INC. other comprehensive income (loss), net of tax for the quarter ending 2025-12-31 was $0.00.
- KALARIS THERAPEUTICS, INC. other comprehensive income (loss), net of tax for the quarter ending 2025-09-30 was $6.00K.
- KALARIS THERAPEUTICS, INC. other comprehensive income (loss), net of tax for fiscal 2025 was $6.00K.
- KALARIS THERAPEUTICS, INC. other comprehensive income (loss), net of tax for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- KALARIS THERAPEUTICS, INC. other comprehensive income (loss), net of tax for fiscal 2023 was $406.00K.
- KALARIS THERAPEUTICS, INC. other comprehensive income (loss), net of tax for fiscal 2022 was -$313.00K.
| Period end | Other Comprehensive Income (Loss), Net of Tax 3 month | Other Comprehensive Income (Loss), Net of Tax 3 month as first filed | Other Comprehensive Income (Loss), Net of Tax 6 month | Other Comprehensive Income (Loss), Net of Tax 9 month | Other Comprehensive Income (Loss), Net of Tax 9 month as first filed | Other Comprehensive Income (Loss), Net of Tax 12 month | Other Comprehensive Income (Loss), Net of Tax 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$24.00K 10-Q · filed 2026-08-11 | -$79.00K 10-Q · filed 2026-08-11 | -$79.00K derived: sum of 3 quarters · filed 2026-08-11 | -$73.00K derived: sum of 4 quarters · filed 2026-08-11 | |||
| 2026-03-31 | -$55.00K 10-Q · filed 2026-05-12 | -$55.00K derived: sum of 2 quarters · filed 2026-05-12 | -$49.00K derived: sum of 3 quarters · filed 2026-05-12 | -$49.00K derived: sum of 4 quarters · filed 2026-08-11 | |||
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-17 | $6.00K derived: sum of 2 quarters · filed 2026-03-17 | $6.00K derived: sum of 3 quarters · filed 2026-08-11 | $6.00K 10-K · filed 2026-03-17 | |||
| 2025-09-30 | $6.00K 10-Q · filed 2025-11-12 | $6.00K derived: sum of 2 quarters · filed 2026-08-11 | $6.00K 10-Q · filed 2025-11-12 | $6.00K derived: sum of 4 quarters · filed 2026-08-11 | |||
| 2025-06-30 | $0.00 10-Q · filed 2026-08-11 | $0.00 10-Q · filed 2026-08-11 | $0.00 derived: sum of 3 quarters · filed 2026-08-11 | $0.00 derived: sum of 4 quarters · filed 2026-08-11 | |||
| 2025-03-31 | $0.00 10-Q · filed 2026-05-12 | $0.00 derived: sum of 2 quarters · filed 2026-05-12 | $0.00 derived: sum of 3 quarters · filed 2026-05-12 | -$1.00K derived: sum of 4 quarters · filed 2026-05-12 | |||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-17 | $0.00 derived: sum of 2 quarters · filed 2026-03-17 | -$1.00K derived: sum of 3 quarters · filed 2026-03-17 | $0.00 10-K · filed 2026-03-17 | -$73.00K 10-K · filed 2025-03-07 | ||
| 2024-09-30 | $0.00 10-Q · filed 2025-11-12 | $5.00K 10-Q · filed 2024-11-12 | -$1.00K derived: sum of 2 quarters · filed 2025-11-12 | $0.00 10-Q · filed 2025-11-12 | -$72.00K 10-Q · filed 2024-11-12 | $61.00K derived: sum of 4 quarters · filed 2025-11-12 | |
| 2024-06-30 | -$1.00K 10-Q · filed 2024-08-09 | -$77.00K 10-Q · filed 2024-08-09 | $61.00K derived: sum of 3 quarters · filed 2025-03-07 | $86.00K derived: sum of 4 quarters · filed 2025-03-07 | |||
| 2024-03-31 | -$76.00K 10-Q · filed 2024-05-13 | $62.00K derived: sum of 2 quarters · filed 2025-03-07 | $87.00K derived: sum of 3 quarters · filed 2025-03-07 | $163.00K derived: sum of 4 quarters · filed 2025-03-07 | |||
| 2023-12-31 | $138.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-07 | $163.00K derived: sum of 2 quarters · filed 2025-03-07 | $239.00K derived: sum of 3 quarters · filed 2025-03-07 | $406.00K 10-K · filed 2025-03-07 | |||
| 2023-09-30 | $25.00K 10-Q · filed 2024-11-12 | $101.00K derived: sum of 2 quarters · filed 2024-11-12 | $268.00K 10-Q · filed 2024-11-12 | $363.00K derived: sum of 4 quarters · filed 2024-11-12 | |||
| 2023-06-30 | $76.00K 10-Q · filed 2024-08-09 | $243.00K 10-Q · filed 2024-08-09 | $338.00K derived: sum of 3 quarters · filed 2024-08-09 | $219.00K derived: sum of 4 quarters · filed 2024-08-09 | |||
| 2023-03-31 | $167.00K 10-Q · filed 2024-05-13 | $262.00K derived: sum of 2 quarters · filed 2024-05-13 | $143.00K derived: sum of 3 quarters · filed 2024-05-13 | $49.00K derived: sum of 4 quarters · filed 2024-05-13 | |||
| 2022-12-31 | $95.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-15 | -$24.00K derived: sum of 2 quarters · filed 2024-03-15 | -$118.00K derived: sum of 3 quarters · filed 2024-03-15 | -$313.00K 10-K · filed 2024-03-15 | |||
| 2022-09-30 | -$119.00K 10-Q · filed 2023-11-02 | -$213.00K derived: sum of 2 quarters · filed 2023-11-02 | -$408.00K 10-Q · filed 2023-11-02 | -$430.00K derived: sum of 4 quarters · filed 2023-11-02 | |||
| 2022-06-30 | -$94.00K 10-Q · filed 2023-08-03 | -$289.00K 10-Q · filed 2023-08-03 | -$311.00K derived: sum of 3 quarters · filed 2023-08-03 | -$419.00K derived: sum of 4 quarters · filed 2023-08-03 | |||
| 2022-03-31 | -$195.00K 10-Q · filed 2023-05-04 | -$217.00K derived: sum of 2 quarters · filed 2023-05-04 | -$325.00K derived: sum of 3 quarters · filed 2023-05-04 | -$363.00K derived: sum of 4 quarters · filed 2023-05-04 | |||
| 2021-12-31 | -$22.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-15 | -$130.00K derived: sum of 2 quarters · filed 2023-02-15 | -$168.00K derived: sum of 3 quarters · filed 2023-02-15 | -$43.00K 10-K · filed 2023-02-15 | |||
| 2021-09-30 | -$108.00K 10-Q · filed 2022-11-03 | -$146.00K derived: sum of 2 quarters · filed 2022-11-03 | -$21.00K 10-Q · filed 2022-11-03 | -$92.00K derived: sum of 4 quarters · filed 2022-11-03 | |||
| 2021-06-30 | -$38.00K 10-Q · filed 2022-08-04 | $87.00K 10-Q · filed 2022-08-04 | $16.00K derived: sum of 3 quarters · filed 2022-08-04 | -$135.00K derived: sum of 4 quarters · filed 2022-08-04 | |||
| 2021-03-31 | $125.00K 10-Q · filed 2022-05-05 | $54.00K derived: sum of 2 quarters · filed 2022-05-05 | -$97.00K derived: sum of 3 quarters · filed 2022-05-05 | -$231.00K derived: sum of 4 quarters · filed 2022-05-05 | |||
| 2020-12-31 | -$71.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-10 | -$222.00K derived: sum of 2 quarters · filed 2022-02-10 | -$356.00K derived: sum of 3 quarters · filed 2022-02-10 | -$180.00K 10-K · filed 2022-02-10 | |||
| 2020-09-30 | -$151.00K 10-Q · filed 2021-11-05 | -$285.00K derived: sum of 2 quarters · filed 2021-11-05 | -$109.00K 10-Q · filed 2021-11-05 | -$143.00K derived: sum of 4 quarters · filed 2021-11-05 | |||
| 2020-06-30 | -$134.00K 10-Q · filed 2021-08-06 | $42.00K 10-Q · filed 2021-08-06 | $8.00K derived: sum of 3 quarters · filed 2021-08-06 | -$19.00K derived: sum of 4 quarters · filed 2021-08-06 | |||
| 2020-03-31 | $176.00K 10-Q · filed 2021-05-06 | $142.00K derived: sum of 2 quarters · filed 2021-05-06 | $115.00K derived: sum of 3 quarters · filed 2021-05-06 | $244.00K derived: sum of 4 quarters · filed 2021-05-06 | |||
| 2019-12-31 | -$34.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-12 | -$61.00K derived: sum of 2 quarters · filed 2021-02-12 | $68.00K derived: sum of 3 quarters · filed 2021-02-12 | $68.00K 10-K · filed 2021-02-12 | |||
| 2019-09-30 | -$27.00K 10-Q · filed 2020-11-10 | $102.00K derived: sum of 2 quarters · filed 2020-11-10 | $102.00K 10-Q · filed 2020-11-10 | ||||
| 2019-06-30 | $129.00K 10-Q · filed 2020-09-02 | $129.00K 10-Q · filed 2020-09-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |